Proteon Therapeutics' Grant

Proteon Therapeutics raised a round of funding on June 21, 2004.

Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a human recombinant protein that aims to permanently dilate segments of blood vessels, blocks vasospasm, and reduce the formatio…

Articles about Proteon Therapeutics' Grant: